Added to YB: 2025-01-02
Pitch date: 2024-12-30
NVO [bullish]
Novo Nordisk A/S
-40.08%
current return
Author Info
No bio for this author
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
Market Cap
DKK 1.4T
Pitch Price
DKK 83.74
Price Target
N/A
Dividend
3.64%
EV/EBITDA
8.92
P/E
13.70
EV/Sales
4.72
Sector
Pharmaceuticals
Category
growth
10 Stocks to watch in 2025 - Novo Nordisk A/S
NVO: Ozempic & Wegovy drive stock surge. Only competitor is Eli Lilly. 2-year manufacturing lead. Novo Nordisk Foundation majority shareholder ensures long-term focus, takeover protection. Strong market position in weight loss drugs, potential for continued growth.
Read full article (1 min)